BERLIN (GenomeWeb) – Qiagen has been marketing its GeneReader next-generation sequencing system as a complete solution — with an automated sample prep, assay, and informatics workflow that includes instrumentation, reagents, and software for analysis and clinical reporting — to molecular pathology and diagnostics laboratories, initially for oncology applications.

At the Association for Molecular Pathology's AMP Global Congress in Berlin this week, several customers and users of the GeneReader presented results from initial studies conducted on the platform.